Wei W Huang

US Patent:

6614804, Sep 2, 2003

Filed:

Mar 22, 1999

Appl. No.:

09/273697

Inventors:

Andrew T. McFadden - Cupertino CA
Mark Wagner - San Mateo CA
Wei Huang - Mountain View CA
Dean J. Blackketter - San Francisco CA
Michael A. Killianey - San Mateo CA
Alan G. Bishop - Campbell CA

Assignee:

WEBTV Networks, Inc. - Mountain View CA

International Classification:

H04J 316

US Classification:

370468, 370316, 709226

Abstract:

The invention involves transmission download of data to plural, mass storage medium-based remote users of content or software upgrades or multiple versions. Optionally provided are pre-download scheduling of one or more future download sessions and post-download remote scripted software execution by the remote clients. For purposes of more efficient use of the transmission link, low-volume scheduling information or content are transmitted within designated narrow-bandwidth sub-channels or trickle streams allocated within the broad bandwidth of the transmission channel and such allocation may be dynamic to vary the allocation based upon relative high-volume, high-speed and low-volume, low-speed demands. The invention is implemented in software residing primarily in the server computer connected with the transmission provider. The software schedules allotted bandwidth within the broadcast band of the transmission link and formats high-volume data for transmission within sub-allocation channels logically devised therein.

US Patent:

6768142, Jul 27, 2004

Filed:

May 8, 2002

Appl. No.:

10/140965

Inventors:

Anwar Ali - San Jose CA
Tauman T. Lau - San Jose CA
Max M. Yeung - San Jose CA
Ken Nguyen - San Jose CA
Wei Huang - San Jose CA

Assignee:

LSI Logic Corporation - Milpitas CA

International Classification:

H01L 2710

US Classification:

257203, 257786, 257782, 257459, 257202, 257207, 257208, 257211, 257784, 257779, 257780, 257773, 257775, 257776, 257691, 438128, 438129, 438612, 438666

Abstract:

A method for designing an input output cell of an integrated circuit. The input output cell has a required area, a width, and a height. The bonding pad pitch length between adjacent bonding pads of the integrated circuit is measured. The width of the input output cell is specified to be substantially equal to the bonding pad pitch length. The required area is divided by the width to determine a first value, and the height of the input output cell is specified to be substantially equal to the first value. In this manner, the width of the input output cells is no greater than the distance between two adjacent bonding pads, and thus the input output cells can be placed very close together, facilitating their use in input output limited integrated circuit designs. However, the height of the input output cells is no greater than is necessary to enclose the required area of the input output cell, thus facilitating their use in core limited integrated circuit designs. In various preferred embodiments, the bonding pads for the input output cells are disposed within their surface areas, thereby further reducing the surface area of the integrated circuit that is required for the input output functions of the integrated circuit.

US Patent:

6925626, Aug 2, 2005

Filed:

Aug 13, 2003

Appl. No.:

10/640738

Inventors:

Ken Nguyen - San Jose CA, US
Wei Huang - Fremont CA, US

Assignee:

LSI Logic Corporation - Milpitas CA

International Classification:

G06F017/50

US Classification:

716 12

Abstract:

A method of routing a metal layer trace in an integrated circuit die includes steps of: (a) receiving as input a netlist of an integrated circuit die; (b) selecting a redistribution layer trace from the netlist for routing the redistribution layer trace between an I/O pad of the integrated circuit die and a termination point; (c) comparing a trace width of the redistribution layer trace with a maximum trace width limit; and (d) if the trace width of the redistribution layer trace exceeds the maximum trace width limit, then routing the redistribution layer trace as a plurality of separate parallel traces each having a trace width that is less than the selected maximum trace width limit.

US Patent:

7070921, Jul 4, 2006

Filed:

Apr 27, 2001

Appl. No.:

09/844655

Inventors:

Wei Huang - Santa Clara CA, US
Merl F. Hoekstra - Cardiff By The Sea CA, US
J. Richard Sportsman - Palo Alto CA, US
Ewald A. Terpetschnig - Austin TX, US

Assignee:

Molecular Devices Corporation - Sunnyvale CA

International Classification:

G01N 21/75

US Classification:

435 4, 435 6, 435 71, 435 911, 435 912, 4352831, 4352852, 4352872, 436164, 436171, 436172, 436800, 436805

Abstract:

Assays for detecting molecular modifications such as phosphate modifications and the presence and/or activity of enzymes and other agents involved in facilitating or otherwise regulating such modifications.

US Patent:

7097970, Aug 29, 2006

Filed:

Jun 4, 2001

Appl. No.:

09/874475

Inventors:

Christos J. Petropoulos - Half Moon Bay CA, US
Neil T. Parkin - Belmont CA, US
Jeanette M. Whitcomb - San Mateo CA, US
Wei Huang - Foster City CA, US

Assignee:

Monogram Biosciences, Inc. - South San Francisco CA

International Classification:

C12Q 1/70

US Classification:

435 5, 435 6, 435 71, 435 721, 435 691, 4353201, 514 44, 530 2372

Abstract:

The invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient infected by the virus; (b) co-transfecting into a first cell (i) the nucleic acid of step (a), and (ii) a viral expression vector which lacks a nucleic acid encoding an envelope protein, and which comprises an indicator nucleic acid which produces a detectable signal, such that the first cell produces viral particles comprising the envelope protein encoded by the nucleic acid obtained from the patient; (c) contacting the viral particles produced in step (b) with a second cell in the presence of the compound, wherein the second cell expresses a cell surface receptor to which the virus binds; (d) measuring the amount of signal produced by the second cell in order to determine the infectivity of the viral particles; and (e) comparing the amount of signal measured in step (d) with the amount of signal produced in the absence of the compound, wherein a reduced amount of signal measured in the presence of the compound indicates that the compound inhibits entry of the virus into the second cell.

US Patent:

7107561, Sep 12, 2006

Filed:

Aug 9, 2004

Appl. No.:

10/914657

Inventors:

Anwar Ali - San Jose CA, US
Wei Huang - San Jose CA, US

Assignee:

LSI Logic Corporation - Milpitas CA

International Classification:

G06F 17/50
G06F 9/45

US Classification:

716 10, 716 13

Abstract:

A method and computer program are disclosed for reducing routing congestion in an integrated circuit design that include steps of: (a) receiving as input a design for an integrated circuit die having an inner metal layer and a top metal layer wherein the design includes electrical constraints of each of a plurality of I/O circuits in the integrated circuit die; (b) selecting a number of vias for a via array to form an electrical connection between the inner metal layer and the top metal layer of the integrated circuit die that connects a solder bump formed on the top metal layer to a corresponding one of the plurality of I/O circuits wherein the number of vias is selected to satisfy the electrical constraints of the corresponding one of the plurality of I/O circuits; and (c) generating as output the number of vias determined for the via array.

US Patent:

7169551, Jan 30, 2007

Filed:

Dec 29, 2005

Appl. No.:

11/323189

Inventors:

Christos J. Petropoulos - Half Moon Bay CA, US
Neil T. Parkin - Belmont CA, US
Jeanette Whitcomb - San Mateo CA, US
Wei Huang - Foster City CA, US

Assignee:

Monogram Biosciences, Inc. - South San Franisco CA

International Classification:

C12Q 1/70

US Classification:

435 5, 435 6, 435 71, 435 721, 4353201, 536 2372

Abstract:

The invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient infected by the virus; (b) co-transfecting into a first cell (i) the nucleic acid of step (a), and (ii) a viral expression vector which lacks a nucleic acid encoding an envelope protein, and which comprises an indicator nucleic acid which produces a detectable signal, such that the first cell produces viral particles comprising the envelope protein encoded by the nucleic acid obtained from the patient; (c) contacting the viral particles produced in step (b) with a second cell in the presence of the compound, wherein the second cell expresses a cell surface receptor to which the virus binds; (d) measuring the amount of signal produced by the second cell in order to determine the infectivity of the viral particles; and (e) comparing the amount of signal measured in step (d) with the amount of signal produced in the absence of the compound, wherein a reduced amount of signal measured in the presence of the compound indicates that the compound inhibits entry of the virus into the second cell.

US Patent:

7235356, Jun 26, 2007

Filed:

Sep 21, 2005

Appl. No.:

11/233461

Inventors:

Christos J. Petropoulos - Half Moon Bay CA, US
Neil T. Parkin - Belmont CA, US
Jeanette Whitcomb - San Mateo CA, US
Wei Huang - Foster City CA, US

Assignee:

Monogram Biosciences, Inc. - South San Franisco CA

International Classification:

C12Q 1/70

US Classification:

435 5, 435 6, 435 71, 435 721, 4353201, 536 2372

Abstract:

The invention provides a method for identifying whether a compound inhibits entry of a virus into a cell which comprises: (a) obtaining nucleic acid encoding a viral envelope protein from a patient infected by the virus; (b) co-transfecting into a first cell (i) the nucleic acid of step (a), and (ii) a viral expression vector which lacks a nucleic acid encoding an envelope protein, and which comprises an indicator nucleic acid which produces a detectable signal, such that the first cell produces viral particles comprising the envelope protein encoded by the nucleic acid obtained from the patient; (c) contacting the viral particles produced in step (b) with a second cell in the presence of the compound, wherein the second cell expresses a cell surface receptor to which the virus binds; (d) measuring the amount of signal produced by the second cell in order to determine the infectivity of the viral particles; and (e) comparing the amount of signal measured in step (d) with the amount of signal produced in the absence of the compound, wherein a reduced amount of signal measured in the presence of the compound indicates that the compound inhibits entry of the virus into the second cell.